• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻及绝经前子宫内膜样子宫内膜癌患者卵巢受累的危险因素。

Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.

作者信息

Li Jun, Zhu Qin, Yang Bingyi, Ning Chengcheng, Liu Xiaoxia, Luo Xuezhen, Chen Xiaojun

机构信息

Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, China; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China.

Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, China.

出版信息

Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:151-154. doi: 10.1016/j.ejogrb.2018.01.030. Epub 2018 Jan 31.

DOI:10.1016/j.ejogrb.2018.01.030
PMID:29408747
Abstract

OBJECTIVE

This study aimed to investigate the incidence of ovarian malignant involvement in young and premenopausal endometrioid endometrial cancer and study the possible risk factors.

METHODS

Premenopausal patients 45 years of age or younger with endometrioid endometrial cancer treated at the OB/GYN Hospital of Fudan University between 2009 and 2013 were identified. The incidence of ovarian malignant involvement in young and premenopausal endometrioid endometrial cancer patients were calculated and the possible risk factors were investigated.

RESULTS

A total of 144 younger (age ≤ 45, premenopausal) patients with endometrioid endometrial cancer were identified and coexisting malignant ovarian neoplasms were detected in 6 patients. Univariate analysis revealed that deeper myometrial invasion, positive lymphonode metastasis, positive LVSI, and high histologic grade (G2-G3) were associated with ovarian involvement in younger endometrial cancer patients. However, multivariate analysis revealed that only deep myometrial invasion was an independent risk factors for ovarian involvement (OR = 12.81, P = 0.046).

CONCLUSION

In conclusions, the incidence of coexisting ovarian malignant neoplasms in young and premenopausal patients with endometrioid endometrial cancer is low, and these findings may facilitate preoperative counseling of patients and decision making at the time of surgery.

摘要

目的

本研究旨在调查年轻及绝经前子宫内膜样腺癌患者卵巢恶性受累的发生率,并研究可能的危险因素。

方法

确定2009年至2013年期间在复旦大学附属妇产科医院接受治疗的45岁及以下绝经前子宫内膜样腺癌患者。计算年轻及绝经前子宫内膜样腺癌患者卵巢恶性受累的发生率,并调查可能的危险因素。

结果

共确定了144例年龄较小(年龄≤45岁,绝经前)的子宫内膜样腺癌患者,其中6例检测到并存恶性卵巢肿瘤。单因素分析显示,肌层浸润深度更深、淋巴结转移阳性、LVSI阳性和高组织学分级(G2-G3)与年轻子宫内膜癌患者的卵巢受累有关。然而,多因素分析显示,只有肌层浸润深度是卵巢受累的独立危险因素(OR = 12.81,P = 0.046)。

结论

总之,年轻及绝经前子宫内膜样腺癌患者并存恶性卵巢肿瘤的发生率较低,这些发现可能有助于患者术前咨询和手术时的决策。

相似文献

1
Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.年轻及绝经前子宫内膜样子宫内膜癌患者卵巢受累的危险因素。
Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:151-154. doi: 10.1016/j.ejogrb.2018.01.030. Epub 2018 Jan 31.
2
Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma.绝经前临床Ⅰ期子宫内膜样腺癌患者卵巢恶性转移的术前预测因素分析。
Sci Rep. 2021 Jan 13;11(1):1219. doi: 10.1038/s41598-020-78953-4.
3
[Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].同步原发性子宫内膜癌和卵巢癌的临床病理及生存分析
Zhonghua Fu Chan Ke Za Zhi. 2018 Dec 25;53(12):816-822. doi: 10.3760/cma.j.issn.0529-567x.2018.12.004.
4
Ovarian preservation in young women with endometrial cancer of endometrioid histology.子宫内膜样组织学类型的年轻子宫内膜癌女性患者的卵巢保留
Acta Obstet Gynecol Scand. 2015 Apr;94(4):430-4. doi: 10.1111/aogs.12588. Epub 2015 Mar 1.
5
Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.早期低风险子宫内膜癌绝经前女性卵巢保留的风险分层临床病理标准。
Int J Gynaecol Obstet. 2020 Sep;150(3):385-391. doi: 10.1002/ijgo.13254. Epub 2020 Jun 26.
6
Ovarian involvement in endometrioid adenocarcinoma of uterus.卵巢受累于子宫子宫内膜样腺癌。
Gynecol Oncol. 2015 Sep;138(3):532-5. doi: 10.1016/j.ygyno.2015.07.012. Epub 2015 Jul 14.
7
Risk Factors for Lymph Node Metastasis among Lymphovascular Space Invasion-Positive Women with Endometrioid Endometrial Cancer Clinically Confined to the Uterus.脉管侵犯阳性且局限于子宫的子宫内膜样型子宫内膜癌患者发生淋巴结转移的风险因素。
Oncol Res Treat. 2018;41(12):750-754. doi: 10.1159/000492585. Epub 2018 Nov 13.
8
[Study of the risk factors for ovarian metastasis in patients with endometrial carcinoma].[子宫内膜癌患者卵巢转移危险因素的研究]
Zhonghua Fu Chan Ke Za Zhi. 2008 May;43(5):352-5.
9
The Value of Preoperative CA 125 Levels in Prediction of Myometrial Invasion in Patients with Early-stage Endometrioid- type Endometrial Cancer.术前CA 125水平在早期子宫内膜样型子宫内膜癌患者子宫肌层浸润预测中的价值
Asian Pac J Cancer Prev. 2016;17(2):497-501. doi: 10.7314/apjcp.2016.17.2.497.
10
[Endometrial cancer, turned out to be an endometroid ovarian cancer stage II].[子宫内膜癌,结果是II期子宫内膜样卵巢癌]
Akush Ginekol (Sofiia). 2011;50(6):48-50.

引用本文的文献

1
Young Women With Endometrial Cancer: A Portuguese Perspective.患有子宫内膜癌的年轻女性:葡萄牙视角。
Cancer Diagn Progn. 2025 Sep 1;5(5):606-613. doi: 10.21873/cdp.10475. eCollection 2025 Sep-Oct.
2
NRDR Inhibits the Migration of Endometrial Cancer Cells and Affects Their Gene Expression.核苷酸还原酶抑制因子(NRDR)抑制子宫内膜癌细胞的迁移并影响其基因表达。
Scientifica (Cairo). 2025 Jul 7;2025:2495655. doi: 10.1155/sci5/2495655. eCollection 2025.
3
Risk assessment of extra-uterine involvement and prognosis in young type I endometrial carcinoma with high or moderate differentiation and less than 1/2 myometrial invasion.
高分化或中分化且肌层浸润小于1/2的年轻Ⅰ型子宫内膜癌宫外受累及预后的风险评估
Aging (Albany NY). 2024 Apr 3;16(7):6445-6454. doi: 10.18632/aging.205714.
4
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.分子和病理数据指导子宫内膜样子宫内膜癌患者选择卵巢保留。
Int J Gynecol Cancer. 2024 May 6;34(5):697-704. doi: 10.1136/ijgc-2023-005194.
5
Development and validation of a nomogram for predicting overall survival in patients with early-onset endometrial cancer.制定并验证预测早发性子宫内膜癌患者总生存期的列线图。
BMC Cancer. 2023 Dec 14;23(1):1230. doi: 10.1186/s12885-023-11682-9.
6
Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.预测子宫内膜癌卵巢转移风险的预警模型的建立与验证。
Medicine (Baltimore). 2023 Oct 13;102(41):e35439. doi: 10.1097/MD.0000000000035439.
7
Fertility preservation in gynecologic cancer patients.妇科癌症患者的生育力保存
Rev Bras Ginecol Obstet. 2023 Mar;45(3):161-168. doi: 10.1055/s-0043-1768564. Epub 2023 May 24.
8
Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview.保留生育功能治疗 I 期及低级别子宫内膜癌:最新综述。
Int J Mol Sci. 2021 Oct 31;22(21):11825. doi: 10.3390/ijms222111825.
9
Developing a validated nomogram for predicting ovarian metastasis in endometrial cancer patients: a retrospective research.开发用于预测子宫内膜癌患者卵巢转移的验证诺模图:一项回顾性研究。
Arch Gynecol Obstet. 2022 Mar;305(3):719-729. doi: 10.1007/s00404-021-06214-4. Epub 2021 Sep 8.
10
Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma.绝经前临床Ⅰ期子宫内膜样腺癌患者卵巢恶性转移的术前预测因素分析。
Sci Rep. 2021 Jan 13;11(1):1219. doi: 10.1038/s41598-020-78953-4.